| A multi-centre, prospective, non-interventional single-arm study investigating clinical parameters associated with the use of once-daily oral semaglutide in a real-world adult |
Ongoing |
Oral semaglutide (Rybelsus®) |
4 |
NN9924-4542 |
Specialized Medical Center (Riyadh),My Clinic (Jeddah),Dallah Hospital (Riyadh),Dr. Sulaiman Al-Habib Medical Group (Riyadh),Dr. Soliman Fakeeh Hospital (Jeddah),Saudi German Hospital (Jeddah),Almoosa Hospital,Mouwasat Hospital |
| A Retrospective Chart Review Combined with a Prospective Cross-sectional Survey and Interviews on Patients with Type 2 Diabetes Mellitus to Assess Effectiveness of Adding SodiumGlucose Co-transporter 2 Inhibitor to Gliclazide Modified Release |
Ongoing |
SodiumGlucose Co-transporter 2 Inhibitor added to Gliclazide Modified Release |
4 |
DIM-05762 |
King Khalid University Hospital (Riyadh),King Abdulaziz University Hospital (Jeddah),Ghassan Najeeb Pharaon hospital (Jeddah) |
| A Real-World Study to Assess the Disease Control of Moderate to Severe Atopic Dermatitis in Patients Receiving Dupilumab Therapy, with Atopic Dermatitis Control Tool in Gulf Countries |
Ongoing |
Dupilumab (Dupixent) |
4 |
OBS17399 |
King Abdulaziz University Hospital (Jeddah),Saudi Airlines Medical Service Center,Dr. Erfan & Bagedo General Hospital (Jeddah),Specialized Medical Center (Riyadh),JC Clinics Complex – Jeddah,Saudi German Hospital (Jeddah),Sulaiman Al Habib Hospital - Al Khobar,King Fahad Medical City (Riyadh),King Faisal General Hospital (Makkah),Al Mana Hospital,King Abdul Aziz Hospital (Makkah) |
| A Phase 3 Open-label Trial of Neoadjuvant Trastuzumab Deruxtecan (T-DXd) Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants with High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11) |
Ongoing |
Trastuzumab-deruxtecan |
3 |
D967RC00001 |
International Medical Center (Jeddah),King Fahad Specialist Hospital (Dammam) |
| Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve): Observations from a retrospective, observational study on patients with SLE in Russia and Saudi Arabia |
Ongoing |
Belimumab |
4 |
OneCDP 215 |
King Fahad Medical City (Riyadh),Aseer Central Hospital (Abha),King Khalid University Hospital (Riyadh),King Fahad specialized hospital (Tabuk) |
| The Effect of Synbiotic Consumption on Glycemic, Inflammatory Markers and Body Composition on Prediabetic and Diabetic Patients: A Double Blinded Randomized Control Trial |
Ongoing |
Synbiotics (Viridian Nutrition) |
3 |
IRB-2019-03-227 |
King Fahad University Hospital (Al-Khobar) , Family and Community Medicine Center (Dammam) |
| ABROCITINIB EXPANDED ACCESS PROTOCOL FOR THE TREATMENT OF ADOLESCENTS AND ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS |
Terminated |
Abrocitinib |
3 |
B7451064 |
King Abdulaziz University Hospital (Jeddah) |
| A randomized, double-blind, placebo controlled study assessing the long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate to severe asthma |
Ongoing |
Dupilumab |
4 |
LPS16676 |
King Saud Medical City (Riyadh),King Abdullah Medical City (Makkah) |
| Effectiveness of Dextrose 5% In Water Local Injection Into Spastic Muscles to manage focal Spasticity (D5W/ Spasticity ). |
Rejected |
DEXTROSE 5% IN WATER |
4 |
TU022144 |
King Fahad specialized hospital (Tabuk) |
| The effects of alpha lipoic acid supplementation on nerve conduction study in patients with diabetic neuropathy |
Rejected |
ALPHA LIPOIC ACID |
4 |
IRB-2022-5 |
King Fahad University Hospital (Al-Khobar) |
